查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
尿路癌全球市場規模研究與預測:按癌症類型、治療類型、分銷渠道和地區分析，2022-2029 年
市場調查報告書
商品編碼
1152006

尿路癌全球市場規模研究與預測:按癌症類型、治療類型、分銷渠道和地區分析，2022-2029 年

Global Urinary Tract Cancer Market Size study & Forecast, by Cancer Type, Treatment Type, and Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

到 2021 年，全球尿路癌症市場價值約為 20.2 億美元，預計在 2022-2029 年的預測期內將以超過 18.6% 的健康增長率增長。

泌尿道癌是一種影響尿道、膀胱和腎盂的癌症。尿道癌是一種影響將尿液從膀胱輸送到體外的管道的癌症。膀胱癌是指排列在膀胱內壁的稱為尿路上皮細胞的健康細胞發生變化並失去控製而形成腫瘤。化學療法和免疫療法被用作尿路癌的治療方法。膀胱癌患病率的增加、私人和政府組織的資金活動增加以及主要市場參與者的戰略舉措是加速市場增長的主要因素。

根據國際世界癌症研究基金會的數據，到 2020 年，全球將報告約 573,278 例膀胱癌新病例，佔所有癌症類型的 3.2%。此外，美國癌症協會估計，到 2022 年，美國將報告大約 81,180 例膀胱癌新病例（大約 61,700 名男性和 19,480 名女性）。大約有 17,100 人死於膀胱癌。此外，在預測期內，新興國家久坐不動的生活方式的激增和不斷增長的醫療基礎設施預計將為膀胱癌市場創造有利的增長前景。然而，與尿路癌相關的高昂治療費用和與處方藥相關的副作用將阻礙整個 2022-2029 年預測期內的市場增長。

全球尿路癌症市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於膀胱癌發病率上升和該地區擁有強大的醫療基礎設施等因素，北美已成為市場份額的主要地區。另一方面，由於老年人口的增加以及超專科醫院、癌症治療中心等的激增，預計亞太地區在預測期內將顯著增長。

本報告中提到的主要市場進入者是:

  • Astellas Pharma Inc.
  • Bristol-Myers Squibb Company
  • Eli Lily and Company
  • Endo International plc.
  • Exelixis, Inc.
  • GlaxoSmithKline Plc.（GSK）
  • Merck KGAA
  • Novartis AG
  • Pfizer Inc.
  • Johnson & Johnson

近期市場動態。

  • 2019 年 4 月，Janssen Pharma的藥物 Barversa（erdafitinib）獲得美國食品藥品監督管理局（FDA）的批准。這種新藥用於治療轉移性尿路上皮癌 (mUC)，這是一種膀胱癌。
  • 2021 年 9 月，MSN Labs 推出了用於治療腎癌的Caborong品牌仿製藥 cabolong。新藥將以20mg/40mg/60mg劑型上市。

全球尿路癌症市場研究範圍。

歷史數據: 2019-2020-2021

基準估計年份:2021

預測期:2022-2029

報告的收入預測、公司排名、競爭格局、增長因素、趨勢

目標細分癌症類型、治療類型、分銷渠道、地區

區域範圍北美、歐洲、亞太地區、拉丁美洲、世界其他地區

購買一份研究覆蓋率報告即可免費定制（相當於最多 8 位分析師的工作時間）。添加或更改國家、地區、航段範圍*

這項研究的目的是定義近年來各個細分市場和國家的市場規模，並預測他們在未來幾年的價值。該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了有關關鍵方面的詳細信息，例如將定義市場未來增長的驅動因素和挑戰。此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。市場的詳細細分和子細分如下所述。

按癌症類型

膀胱癌

尿道癌

輸尿管/腎盆腔癌

按治療類型

化學處理

免疫療法

按銷售渠道

零售店

網上藥店

按地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

意大利

歐洲其他地區

亞太地區

中國

印度

日本

澳大利亞

韓國

其他亞太地區

拉丁美洲

巴西

墨西哥

世界其他地區

目錄

第一章內容提要

  • 市場快照
  • 2019-2029 年按細分劃分的全球市場估計和預測
    • 泌尿道癌市場（按地區）:2019-2029
    • 泌尿道癌症市場:按癌症類型分類，2019-2029
    • 泌尿道癌市場:按治療類型分類，2019-2029
    • 泌尿道癌市場:按分銷渠道，2019-2029
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第二章全球尿路腫瘤市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 產業進化
  • 調查目標年份
  • 貨幣兌換率

第三章尿路癌的全球市場動態

  • 泌尿道癌市場影響分析 (2019-2029)
    • 市場驅動力
      • 膀胱癌患病率增加
      • 來自私人和政府組織的資助活動增加。
      • 主要市場參與者的戰略舉措
    • 市場挑戰
      • 與尿路癌相關的高治療費用
      • 與處方藥相關的副作用
    • 市場機會
      • 久坐不動的生活方式迅速增加
      • 新興國家醫療保健基礎設施的增加

第四章尿路腫瘤全球市場行業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭對手之間的競爭
  • 波特五力模型的未來方法（2019-2029）
  • PEST分析
    • 政治的
    • 經濟的
    • 社會的
    • 技術的
  • 招商引資模式
  • 分析師結論/建議
  • 頂級投資機會
  • 關鍵成功策略

第 5 章風險評估:COVID-19 的影響

  • 評估 COVID-19 對行業的整體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

6 全球尿路癌症市場，按癌症類型

  • 市場快照
  • 全球尿路癌症市場:按癌症類型、性能潛力分析
  • 全球尿路癌症市場，按癌症類型估計和預測（2019-2029）
  • 全球尿路癌症市場，細分分析
    • 膀胱癌
    • 尿道癌
    • 輸尿管/腎盂癌

第 7 章:按治療類型分列的全球尿路癌症市場

  • 市場快照
  • 全球尿路癌症市場:按治療類型、性能-潛力分析
  • 2019-2029 年全球尿路癌症市場、按治療類型估計和預測
  • 尿路癌症市場，細分分析
    • 化學處理
    • 免疫療法

8 全球尿路癌市場，按分銷渠道

  • 市場快照
  • 全球尿路癌症市場:分銷渠道的性能潛力分析
  • 全球尿路癌症市場，按分銷渠道估計和預測（2019-2029）
  • 尿路癌症市場，細分分析
    • 零售藥店
    • 網上藥店

9 全球尿路癌症市場:區域分析

  • 全球尿路癌症市場:按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年按癌症類型估計和預測
      • 2019-2029 年各治療類型的估計和預測
      • 2019-2029 年各分銷渠道的估計和預測
    • 加拿大
  • 歐洲泌尿道癌症市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 歐洲其他地區
  • 亞太地區尿路癌症市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲尿路癌症市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第 10 章 競爭信息

  • 頂級市場戰略
  • 公司簡介
    • Astellas Pharma Inc.
      • 主要信息
      • 概述
      • 財務（如果有數據）
      • 產品概要
      • 近期發展狀況
    • Bristol-Myers Squibb Company
    • Eli Lily and Company
    • Endo International plc.
    • Exelixis, Inc.
    • GlaxoSmithKline Plc.（GSK）
    • Merck KGAA
    • Novartis AG
    • Pfizer Inc.
    • Johnson & Johnson

第十一章調查過程

  • 調查過程
    • 數據挖掘
    • 分析
    • 市場估計
    • 驗證
    • 出版物
  • 調查屬性
  • 調查先決條件

Global Urinary Tract Cancer Market is valued approximately USD 2.02 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 18.6% over the forecast period 2022-2029. Urinary Tract Cancer is a type of cancer that affects urethra, bladder, and renal pelvic. Urethral cancer affects the tube that carries urine from bladder to outside of the body. Whereas in Bladder Cancer the healthy cells in the bladder lining called as urothelial cells, change, and grow out of control and form a tumor. Chemotherapy, and Immunotherapy are used as treatment procedure for treatment of Urinary Tract Cancer. The increasing prevalence of bladder cancer and growing number of funding activities from private & government organizations as well as strategic initiatives from leading market players are key factors accelerating the market growth.

According to the World Cancer Research Fund International - in 2020, around 573278 new cases of bladder cancer were reported worldwide, representing 3.2% of all cancer type. Moreover, as per American Cancer Society's estimates - in 2022, around 81,180 new cases of bladder cancer (about 61,700 in men and 19,480 in women) reported across the United States. In addition, around 17,100 individuals lost their lives due to bladder Cancer. Also, surge in sedentary lifestyle and rising healthcare infrastructure in emerging regions would create lucrative growth prospectus for the market over the forecast period. However, the high treatment cost associated with Urinary tract cancer and side effects associated with prescribed drugs impede the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Urinary Tract Cancer Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share due to factors such as Increasing incidences of bladder cancer as well as availability of robust healthcare infrastructure in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising number of geriatric individuals as well as increasing penetration of super specialty hospitals and cancer care centers in the region.

Major market players included in this report are:

Astellas Pharma Inc.

Bristol-Myers Squibb Company

Eli Lily and Company

Endo International plc.

Exelixis, Inc.

GlaxoSmithKline Plc. (GSK)

Merck KGAA

Novartis AG

Pfizer Inc.

Johnson & Johnson

Recent Developments in the Market:

  • In April 2019, Janssen Pharmaceutical received the US Food and Drug Administration (FDA) approval for the drug Balversa (erdafitinib). This new drug is intended for treatment of metastatic urothelial carcinoma (mUC), a type of bladder cancer.
  • In September 2021, MSN Labs launched Cabolong, a branded generic of Cabozantinib, for the treatment of renal cancer. This new drug would be available in 20mg/40mg/60mg formulation.

Global Urinary Tract Cancer Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Cancer Type, Treatment Type, Distribution Channel, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Cancer type

Bladder Cancer

Urethral cancer

Ureteric and Renal Pelvic Cancer

By Treatment Type

Chemotherapy

Immunotherapy

By Distribution Channel

Retail Pharmacy

Online Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Urinary Tract Cancer Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Urinary Tract Cancer Market, by Cancer Type, 2019-2029 (USD Billion)
    • 1.2.3. Urinary Tract Cancer Market, by Treatment Type, 2019-2029 (USD Billion)
    • 1.2.4. Urinary Tract Cancer Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Urinary Tract Cancer Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Urinary Tract Cancer Market Dynamics

  • 3.1. Urinary Tract Cancer Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of bladder cancer.
      • 3.1.1.2. Growing number of funding activities from private & government organizations.
      • 3.1.1.3. Strategic initiatives from leading market players.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High treatment cost associated with Urinary tract cancer.
      • 3.1.2.2. Side effects associated with prescribed drugs.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Surge in sedentary lifestyle.
      • 3.1.3.2. Rising healthcare infrastructure in emerging regions.

Chapter 4. Global Urinary Tract Cancer Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Urinary Tract Cancer Market, by Cancer Type

  • 6.1. Market Snapshot
  • 6.2. Global Urinary Tract Cancer Market by Cancer Type, Performance - Potential Analysis
  • 6.3. Global Urinary Tract Cancer Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
  • 6.4. Urinary Tract Cancer Market, Sub Segment Analysis
    • 6.4.1. Bladder Cancer
    • 6.4.2. Urethral cancer
    • 6.4.3. Ureteric and Renal Pelvic Cancer

Chapter 7. Global Urinary Tract Cancer Market, by Treatment Type

  • 7.1. Market Snapshot
  • 7.2. Global Urinary Tract Cancer Market by Treatment Type, Performance - Potential Analysis
  • 7.3. Global Urinary Tract Cancer Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
  • 7.4. Urinary Tract Cancer Market, Sub Segment Analysis
    • 7.4.1. Chemotherapy
    • 7.4.2. Immunotherapy

Chapter 8. Global Urinary Tract Cancer Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Urinary Tract Cancer Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Urinary Tract Cancer Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Urinary Tract Cancer Market, Sub Segment Analysis
    • 8.4.1. Retail Pharmacy
    • 8.4.2. Online Pharmacy

Chapter 9. Global Urinary Tract Cancer Market, Regional Analysis

  • 9.1. Urinary Tract Cancer Market, Regional Market Snapshot
  • 9.2. North America Urinary Tract Cancer Market
    • 9.2.1. U.S. Urinary Tract Cancer Market
      • 9.2.1.1. Cancer Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Treatment Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Urinary Tract Cancer Market
  • 9.3. Europe Urinary Tract Cancer Market Snapshot
    • 9.3.1. U.K. Urinary Tract Cancer Market
    • 9.3.2. Germany Urinary Tract Cancer Market
    • 9.3.3. France Urinary Tract Cancer Market
    • 9.3.4. Spain Urinary Tract Cancer Market
    • 9.3.5. Italy Urinary Tract Cancer Market
    • 9.3.6. Rest of Europe Urinary Tract Cancer Market
  • 9.4. Asia-Pacific Urinary Tract Cancer Market Snapshot
    • 9.4.1. China Urinary Tract Cancer Market
    • 9.4.2. India Urinary Tract Cancer Market
    • 9.4.3. Japan Urinary Tract Cancer Market
    • 9.4.4. Australia Urinary Tract Cancer Market
    • 9.4.5. South Korea Urinary Tract Cancer Market
    • 9.4.6. Rest of Asia Pacific Urinary Tract Cancer Market
  • 9.5. Latin America Urinary Tract Cancer Market Snapshot
    • 9.5.1. Brazil Urinary Tract Cancer Market
    • 9.5.2. Mexico Urinary Tract Cancer Market
  • 9.6. Rest of The World Urinary Tract Cancer Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Astellas Pharma Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Bristol-Myers Squibb Company
    • 10.2.3. Eli Lily and Company
    • 10.2.4. Endo International plc.
    • 10.2.5. Exelixis, Inc.
    • 10.2.6. GlaxoSmithKline Plc. (GSK)
    • 10.2.7. Merck KGAA
    • 10.2.8. Novartis AG
    • 10.2.9. Pfizer Inc.
    • 10.2.10. Johnson & Johnson

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Urinary Tract Cancer Market, report scope
  • TABLE 2. Global Urinary Tract Cancer Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Urinary Tract Cancer Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
  • TABLE 4. Global Urinary Tract Cancer Market estimates & forecasts by Treatment Type 2019-2029 (USD Billion)
  • TABLE 5. Global Urinary Tract Cancer Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Urinary Tract Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Urinary Tract Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Urinary Tract Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Urinary Tract Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Urinary Tract Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Urinary Tract Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Urinary Tract Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Urinary Tract Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Urinary Tract Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Urinary Tract Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Urinary Tract Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Urinary Tract Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Urinary Tract Cancer Market
  • TABLE 71. List of primary sources, used in the study of global Urinary Tract Cancer Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Urinary Tract Cancer Market, research methodology
  • FIG 2. Global Urinary Tract Cancer Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Urinary Tract Cancer Market, key trends 2021
  • FIG 5. Global Urinary Tract Cancer Market, growth prospects 2022-2029
  • FIG 6. Global Urinary Tract Cancer Market, porters 5 force model
  • FIG 7. Global Urinary Tract Cancer Market, pest analysis
  • FIG 8. Global Urinary Tract Cancer Market, value chain analysis
  • FIG 9. Global Urinary Tract Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Urinary Tract Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Urinary Tract Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Urinary Tract Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Urinary Tract Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Urinary Tract Cancer Market, regional snapshot 2019 & 2029
  • FIG 15. North America Urinary Tract Cancer Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Urinary Tract Cancer Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Urinary Tract Cancer Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Urinary Tract Cancer Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Urinary Tract Cancer Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable